Literature DB >> 33123937

Assessment of late-term progression of cardiac allograft vasculopathy in patients with orthotopic heart transplantation using quantitative cardiac 82Rb PET.

Uttam M Shrestha1,2, Maria Sciammarella3, Miguel Hernandez Pampaloni4, Elias H Botvinick4,3, Grant T Gullberg4, Teresa DeMarco3, Youngho Seo4.   

Abstract

The risk stratification and long-term survival of patients with orthotopic heart transplantation (OHT) is impacted by the complication of cardiac allograft vasculopathy (CAV). This study evaluates changes in myocardial blood flow (MBF) and myocardial coronary flow reserve (CFR) in a group of long-term OHT patients using quantitative cardiac 82Rb-positron emission tomography (PET). Twenty patients (7 females and 13 males, mean age = 72.7 ± 12.2 years with CAV and 62.9 ± 7.2 years without CAV and post-OHT mean time = 13.9 years), were evaluated retrospectively using dynamic cardiac 82Rb-PET at rest and regadenoson-induced stress. The patients also underwent selective coronary angiography (SCA) for diagnosis and risk stratification. CAV was diagnosed based on SCA findings and maximal intimal thickness greater than 0.5 mm, as defined by International Society of Heart and Lung Transplantation (ISHLT). Global and regional MBFs were estimated in three vascular territories using the standard 1-tissue compartment model for dynamic 82Rb-PET. The myocardial CFR was also calculated as the ratio of peak stress MBF to rest MBF. Among twenty patients, seven had CAV in, at least, one major coronary artery (ISHLT CAV grade 1 or higher) while 13 patients did not have CAV (NonCAV). Mean rate-pressure products (RPP) at rest were significantly elevated in CAV patients compared to those without CAV (P = 0.002) but it was insignificant at stress (P = NS). There was no significant difference in the stress MBFs between CAV and NonCAV patients (P = NS). However, the difference in RPP-normalized stress MBFs was significant (P = 0.045), while RPP-normalized MBFs at rest was not significant (P = NS). Both CFR and RPP-normalized CFR were significantly lower in CAV compared to NonCAV patients (P < 0.001). There were significant correlations between MBFs and RPPs at rest for both CAV (ρ = 0.764, P = 0.047) and NonCAV patients (ρ = 0.641, P = 0.017), while there were no correlations at stress for CAV (ρ = 0.232, P = NS) and NonCAV patients (ρ = 0.068, P = NS). This study indicates that the resting MBF is higher in late-term post-OHT patients. The high resting MBF and reduced CFR suggest an unprecedented demand of blood flow and blunted response to stress due to impaired vasodilatory capacity that is exacerbated by the presence of CAV.

Entities:  

Keywords:  82Rb-PET; Cardiac allograft vasculopathy; Coronary flow reserve; Dynamic PET; Orthotopic heart transplant; Regadenoson

Mesh:

Substances:

Year:  2020        PMID: 33123937      PMCID: PMC8035159          DOI: 10.1007/s10554-020-02086-y

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  43 in total

Review 1.  The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time.

Authors:  Daniel C Chambers; Roger D Yusen; Wida S Cherikh; Samuel B Goldfarb; Anna Y Kucheryavaya; Kiran Khusch; Bronwyn J Levvey; Lars H Lund; Bruno Meiser; Joseph W Rossano; Josef Stehlik
Journal:  J Heart Lung Transplant       Date:  2017-07-19       Impact factor: 10.247

2.  Factors affecting long-term survival (>10 years) after cardiac transplantation in the cyclosporine era.

Authors:  R John; H A Rajasinghe; S Itescu; S Suratwala; S Suratwalla; K Lietz; A D Weinberg; A Kocher; D M Mancini; R E Drusin; M C Oz; C R Smith; E A Rose; N M Edwards
Journal:  J Am Coll Cardiol       Date:  2001-01       Impact factor: 24.094

3.  PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy.

Authors:  Sharon Chih; Aun Yeong Chong; Fernanda Erthal; Robert A deKemp; Ross A Davies; Ellamae Stadnick; Derek Y So; Christopher Overgaard; George Wells; Lisa M Mielniczuk; Rob S B Beanlands
Journal:  J Am Coll Cardiol       Date:  2018-04-03       Impact factor: 24.094

4.  Myocardial efficiency and sympathetic reinnervation after orthotopic heart transplantation: a noninvasive study with positron emission tomography.

Authors:  F M Bengel; P Ueberfuhr; N Schiepel; S G Nekolla; B Reichart; M Schwaiger
Journal:  Circulation       Date:  2001-04-10       Impact factor: 29.690

5.  Angiotensin-Converting Enzyme Inhibition Early After Heart Transplantation.

Authors:  William F Fearon; Kozo Okada; Jon A Kobashigawa; Yuhei Kobayashi; Helen Luikart; Sean Sana; Tiffany Daun; Steven A Chmura; Seema Sinha; Garett Cohen; Yasuhiro Honda; Michael Pham; David B Lewis; Daniel Bernstein; Alan C Yeung; Hannah A Valantine; Kiran Khush
Journal:  J Am Coll Cardiol       Date:  2017-06-13       Impact factor: 24.094

6.  Donor age is associated with chronic allograft vasculopathy after adult heart transplantation: implications for donor allocation.

Authors:  Alykhan S Nagji; Tjasa Hranjec; Brian R Swenson; John A Kern; James D Bergin; David R Jones; Irving L Kron; Christine L Lau; Gorav Ailawadi
Journal:  Ann Thorac Surg       Date:  2010-07       Impact factor: 4.330

7.  Regional differences in sympathetic reinnervation after human orthotopic cardiac transplantation.

Authors:  R F Wilson; D D Laxson; B V Christensen; A L McGinn; S H Kubo
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

8.  Influence of age and hemodynamics on myocardial blood flow and flow reserve.

Authors:  J Czernin; P Müller; S Chan; R C Brunken; G Porenta; J Krivokapich; K Chen; A Chan; M E Phelps; H R Schelbert
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

9.  Electrophysiological effects of adenosine in the transplanted human heart. Evidence of supersensitivity.

Authors:  K A Ellenbogen; M D Thames; J P DiMarco; H Sheehan; B B Lerman
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

10.  Dobutamine stress echocardiography after cardiac transplantation: implications of donor-recipient age difference.

Authors:  Patrick H Gibson; Fernando Riesgo; Jonathan B Choy; Daniel H Kim; Harald Becher
Journal:  Echo Res Pract       Date:  2015-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.